Paul Kim

Paul H.
Kim is Chief Executive Officer at Matica Biotechnology, Inc. since 2024.
Mr. Kim is Independent Director at Exagen, Inc. since 2023.
Mr. Kim is Chief Financial Officer at Fulgent Therapeutics LLC since 2016.
Mr. Kim is Chief Financial Officer at Fulgent Genetics, Inc. since 2016.
Former roles include Director at WCCT Global, Inc. and PharmAbcine Inc., Principal at Heron Therapeutics, Inc., CG Invites Co., Ltd., and Viro-Med Laboratories, Inc. Controller at Interlink Computer Sciences, Inc. from 1996 to 1998.
Chief Financial Officer at AMCC Enterprise Corp.
from 2002 to 2003.
Chief Financial Officer at Gemalto Cogent, Inc. and Cogent, Inc. from 2004 to 2011.
Audit Manager at Coopers & Lybrand LLP from 1990 to 1996.
Vice President-Finance & Administration at Datafusion, Inc. from 1998 to 1999.
Education includes an undergraduate degree from the University of California, Berkeley in 1989 and an MBA from Tuck School of Business at Dartmouth.